0	Acute and chronic activation of the mTOR pathway in a rat model of temporal lobe epilepsy.
1	We found that acute and chronic biphasic activation of the mTOR signaling pathway are involved in mechanisms of epileptogenesis.
2	Mammalian Target of Rapamycin signaling is involved in Epileptogenesis in the Kainate Rat Model.
3	mTOR signaling mediates mechanisms of epileptogenesis in a rat model of kainate-induced epilepsies.
4	Biphasic mTOR signaling is involved in initiation and progression of epileptogenesis in the kainate rat model of epilepsy.
5	Rapamycin inhibits acute and chronic phases of epileptogenesis.
6	The mammalian target of rapamycin (mTOR) signaling pathway mediates epileptogenesis in the kainate rat model.
7	mTOR inhibition blocks seizure-induced neocortical epilepsy by disrupting two distinct phases of mTOR activation.
8	The mTOR signaling pathway is involved in epileptogenesis.
9	Rapamycin reduces epileptogenesis and neurogenesis in a rat model of kainate-induced seizure activity.
10	A biomarker for human Regulatory T Cells Based on the Down-regulation of the Interleukin-7 Receptor, CD127.
11	The use of IL-7 receptor (CD127) to identify human regulatory T cells.
12	Down-regulation of IL-7R on human T reg cells.
13	Identification of a new biomarker of human T reg cells based on low expression of the IL-7 receptor, CD127.
14	A biomarker for IL-7 receptor expression on human regulatory T cells.
15	The IL-7 Receptor (CD127) Is Down-regulated on a Subset of CD4+ Regulatory T Cells in the Human Peripheral Blood.
16	We show that a subset of human CD4+ T cells characterized by down-regulation of the IL-7 receptor is highly suppressive.
17	CD127 is a useful biomarker for human regulatory T cells
18	The IL-7 receptor (CD127) is a powerful tool for identifying FoxP3+ human regulatory T cells.
19	Identification of an unrecognized marker for human T reg cells.
20	Women with a history of miscarriage may be more vulnerable to depression during the first month postpartum.
21	Women with a history of miscarriage may be more vulnerable to depression during the first month postpartum
22	Women with a history of miscarriage may be more vulnerable to depression during the first month postpartum than women without prior miscarriage, but this effect does not appear to persist beyond this time period.
23	Women with a history of miscarriage may be more vulnerable to depression during the first month postpartum
24	Women with a history of miscarriage may be more vulnerable to depression during the first month postpartum than women without prior miscarriage.
25	During the first month postpartum, women with a history of miscarriage may be more vulnerable to depression than women without prior miscarriage
26	Women with a history of miscarriage may be more vulnerable to depression during the first month postpartum than women without prior miscarriage, but this effect does not appear to persist beyond this time period.
27	Women with a history of miscarriage may be more vulnerable to depression during the first month postpartum than women without prior miscarriage
28	Women with a history of miscarriage may be more vulnerable to depression during the first month postpartum than women without prior miscarriage, but this effect does not appear to persist beyond this time period.
29	Women with a history of miscarriage may be more vulnerable to depression during the first month postpartum than women without prior miscarriage.
30	PAR-2 modulation is associated with increased MMP and COX-2 synthesis and activation of inflammatory pathways in human osteoarthritis cartilage/chondrocytes.
31	Phosphorylation of p38, JNK, and NF-B is increased in OA chondrocytes by PAR-2.
32	PAR-2 modulates signalling pathways on chondrocytes and catabolic factors in OA cartilage.
33	The PAR-2 protein is activated in OA chondrocytes in a catabolic and inflammatory response.
34	PAR-2 mediates the regulation of MMP-1 and COX-2 in OA cartilage via signalling pathways
35	Activation of PAR-2 in OA chondrocytes promotes the synthesis of catabolic factors and signalling pathways involved in inflammation.
36	The proteinase-activated receptor (PAR-2) is expressed and modulated in human osteoarthritis and is involved in the inflammatory process.
37	PAR-2 activation in chondrocytes is involved in the expression of MMPs and COX-2 and in inflammatory mediators in OA cartilage.
38	Our data demonstrate that in situ levels of PAR-2 are significantly increased in OA cartilage compared to normal chondrocytes and that PAR-2-AP modulates catabolic and inflammatory pathways in OA chondrocytes.
39	PAR-2-activated signalling pathways control MMP-1 and MMP-13 and COX-2 synthesis in OA chondrocytes.
40	CH6 Aptamer-Functionalized Lipid Nanoparticles Are a Potential Targeted Delivery System for RNAi-Based Bone Anabolism.
41	The aptamer CH6 enables RNA-mediated gene silencing in vivo via delivery to the cell.
42	Aptamer-functionalized lipid nanoparticles as novel delivery systems for RNA interference-based bone anabolic strategies
43	Aptamer-functionalized lipid nanoparticles enhance RNA interference-based bone anabolic strategies via the specific targeting of osteoblasts.
44	Chondroitin sulfate lipid nanoparticles encapsulating Plekho1 siRNA facilitate osteoblast-specific gene silencing in vivo.
45	Functionalization of lipid nanoparticles with an aptamer that targets osteoblasts could be a new way to improve bone mass by RNAi-based anabolic strategies.
46	Aptamer-functionalized lipid nanoparticles enable RNA interference-based bone anabolic strategies.
47	A novel aptamer-functionalized lipid nanoparticle delivery system targeting osteoblasts to promote bone anabolism.
48	RNA interference-based bone anabolic strategy via osteoblast-specific aptamer-functionalized lipid nanoparticles.
49	Direct osteoblast-specific delivery systems using aptamers and lipid nanoparticles
50	We propose that large CpG islands depleted of activating motifs confer epigenetic memory by recruiting the full repertoire of Polycomb complexes in pluripotent cells.
51	This study maps the repressive activity of Polycomb complexes in human embryonic stem cells, revealing the nature of bivalent chromatin domains in both species.
52	PRC2-only bivalent domains promote the generation of developmental regulator gene promoters in pluripotent cells.
53	Bivalent chromatin domains mark more than 2,000 genes in embryonic stem cells
54	Two classes of bivalent chromatin domains: PRC1-positive and PRC2-only
55	Bivalent domains in embryonic stem cells are associated with PRC1 and PRC2 by chromatin immunoprecipitation-sequencing and can be segregated into two distinct classes.
56	CpG island-specific binding of the Polycomb complexes confers epigenetic memory in ES cells
57	Large CpG islands depleted of activating motifs confer epigenetic memory by recruiting the full repertoire of Polycomb complexes
58	The full repertoire of Polycomb complexes in embryonic stem cells is predicted from the sequences of CpG islands.
59	The conservation of chromatin state and underlying epigenetic state in bivalent domains is based on the sequential recruitment of Polycomb repressive complexes.
60	MicroRNA-196 regulates p-JNK and promotes cell migration and invasion in oral cancer
61	MicroRNA-196 contributes to oral cancer through promoting cell migration and invasion.
62	microRNA-196 : a promising marker of tumor recurrence and metastasis in oral cancer
63	miR-196 promotes oral cancer cell invasion by regulating TIMP1 expression.
64	MicroRNA-196 enhances cell migration and invasion by targeting NME4 expression.
65	MicroRNA-196 promotes oral cancer metastasis.
66	MicroRNA-196 (miR-196) is an important gene expressed in oral cancer cells, and promotes cell migration and invasion.
67	MicroRNA-196 promotes cell migration and invasion in oral cancer.
68	miR-196 contributes to oral cancer by promoting cell migration and invasion.
69	MicroRNA-196 contributes to oral cancer by promoting cell migration and invasion.
70	Human embryonic stem cells can be used to provide a neural precursor cell source for transplantation therapy.
71	Human ES cells represent a source of transplantable neural precursors.
72	This article reports the in vitro differentiation, enrichment, and transplantation of neural precursor cells from human embryonic stem cells for possible nervous system repair.
73	Human embryonic stem cell–derived neural precursors are functional in vivo.
74	In vitro differentiation, enrichment, and transplantation of neural precursor cells from human embryonic stem cells.
75	Differentiation, Enrichment, and Transplantation of Neural Precursors Derived from Human Embryonic Stem Cells
76	Differentiation and transplantation of human embryonic stem cell-derived neural precursors for possible neurorepair.
77	Differentiation, Enrichment, and Transplantation of Neural Precursors from Human Embryonic Stem Cells.
78	Human embryonic stem cells can differentiate into astrocytes and neurons.
79	ES Cells Differentiate and Transform into Neural Precursors for the Repair of Nervous Systems
80	MicroRNAs are a large family of post-transcriptional regulators of gene expression that are 21 nucleotides in length and control many developmental and cellular processes in eukaryotic organisms.
81	The control of miRNA function by numerous protein–protein and protein–RNA interactions has important implications for the cellular context of miRNAs.
82	Regulation of microRNAs by proteins
83	MicroRNAs are under tight regulation.
84	The regulation of microRNAs by protein-RNA interactions.
85	Regulation of microRNA function by protein-RNA interactions.
86	MicroRNAs are regulated by protein–protein and protein–RNA interactions.
87	MicroRNAs are highly complex regulators of gene expression.
88	Regulation of microRNAs RNA by many different regulators including proteins and proteins.
89	miRNAs are regulated by multiple signaling cascades.
90	A better method for comparing two measurement techniques.
91	Correlation is the wrong answer in clinical measurement
92	In clinical measurement comparison of a new measurement technique with an established one is often needed to see whether they agree sufficiently for the new to replace the old.
93	An alternative approach is described.
94	The correlation analysis is not the only option.
95	Clinical measurement comparison of a new measurement technique with an established one is often needed to see whether they agree sufficiently for the new to replace the old.
96	Methods for assessing the repeatability of a measurement technique
97	Comparison of new measurements with established ones.
98	This method of evaluating a method of measurement, based on comparison with an established method, is a simple and straightforward one.
99	Correlation is misleading when assessing measurement methods.
100	This review emphasizes that virulence evolution theory in the context of opportunistic pathogens is constrained by environmental correlations between focal and external settings
101	Virulence evolution theory and opportunistic pathogens: generalists rather than parasites
102	Standard virulence theory assumes that virulence factors are maintained because they aid parasitic exploitation, increasing growth within and/or transmission between hosts.
103	The virulence evolution theory behind opportunistic pathogens is unifying and non-parasitic.
104	The evolution of pathogenicity has been underpinned by assumptions that assume parasitic selection as the main driver of virulence.
105	Virulence evolution in the context of opportunistic pathogens is constrained by correlations between external and focal settings.
106	Standard virulence evolution theory assumes that virulence factors are maintained because they aid parasitic exploitation, increasing growth within and/or transmission between hosts.
107	Virulence evolution theory in the context of opportunistic pathogens highlights the importance of incorporating environments outside a focal virulence site
108	Virulence factors in opportunistic pathogens are maintained for non-parasitic and generalist benefits.
109	The focus on opportunistic pathogens reveals that virulence factors can be maintained for non-parasitic gains in environments other than the focal parasitic site.
110	The interferons represent one of the first lines of host defense against invading pathogens.
111	Interferons can be used to control virus infections.
112	Type I interferons are effective antiviral drugs with potential side effects.
113	The interferons (IFNs) are glycoproteins with strong antiviral activities that represent one of the first lines of host defense against invading pathogens.
114	Interferons are glycoproteins that represent one of the first lines of host defense against invading pathogens.
115	The interferons are proteins that have strong antiviral activities that represent one of the first lines of host defense against invading pathogens.
116	Interferons modulate the immune response against viral infections
117	The interferons represent one of the first lines of host defense against invading pathogens.
118	Interferons represent a major line of defense for the host against viruses.
119	Type I interferons represent a promising therapeutic option for Hepatitis C.
120	A humanized mouse model for studying the preneoplastic state
121	Human xenograft models provide a new approach to explore human preneoplastic gammopathies in vivo.
122	We developed an in vivo model of plasma cell neoplasms to study the interaction between preneoplastic and malignant cells and their host environment.
123	We demonstrate the utility of humanized mouse models for understanding the functional diversity of human tumors.
124	Using human Xenografts to Study Myeloma Precursor States in Mice
125	The humanized mouse allows the study of human xenografts together with human non-malignant cells.
126	An in vivo model reveals progressive growth in preneoplastic plasma cells and is a foundation for understanding the entire spectrum of human plasma cell neoplasia.
127	In vivo Models of Primary Human Neoplasms
128	In vitro xenografts reveal the full complexity of human plasma cell neoplasia
129	Using humanized mice to study the entire spectrum of human plasma cell neoplasia
130	Human Granulomas are Bipolar During Development
131	The molecular hallmarks of granuloma formation are segregated within the human granuloma.
132	This study uses proteomics to map the molecular diversity of granulomas in TB.
133	Granulomas are characterized by distinct proteomic profiles.
134	Granuloma development is dependent on the differential activation of pro-inflammatory and anti-inflammatory pathways.
135	We found that the centers of granulomas have a pro-inflammatory environment.
136	Granulomas contain a pro-inflammatory environment at the granuloma center, whereas the caseum is more anti-inflammatory.
137	Granuloma-specific proteins and lipids segregate pro- and anti-inflammatory pathways.
138	Pro- and anti-inflammatory signals are physically segregated within human granulomas.
139	Human Granulomas Are Partially Anti-inflammatory
140	The first demonstration of lentiviral transgene expression in marmosets
141	First successful creation of transgenic non-human primates that demonstrates gene expression in transgenic offspring.
142	Using lentiviral transduction to produce transgenic marmosets
143	The successful creation of transgenic marmosets provides a new animal model for human disease.
144	Establishment of transgenic marmosets by injection of a lentiviral vector into embryos.
145	Using viral vectors, we successfully created transgenic marmosets with the ability to pass transgenes from mother to offspring.
146	The successful creation of transgenic marmosets provides a new animal model for human disease that has the great advantage of a close genetic relationship with humans.
147	The successful creation of transgenic marmosets provides a new animal model for human disease that has the great advantage of a close genetic relationship with humans.
148	Using lentiviral vectors to make transgenic common marmosets.
149	The ability to produce transgenic marmosets with lentiviral vectors provides a new animal model for human disease.
150	Caspase-11 and caspase-1 activate gasdermin D cleavage to release intramolecular inhibition on the gasdermin-N domain, which triggers pyroptosis.
151	Pyroptosis is triggered by inflammatory caspases by cleaving a linker in gasdermin D and relies on its N domain
152	Inflammatory caspases use a conserved autoinhibitory cleavage event to trigger pyroptosis.
153	''Caspases directly cleave gasdermin D to trigger pyroptosis''.
154	Identification of the molecular mechanism of caspase-mediated pyroptosis identifies the gasdermin family as a key determinant.
155	Gasdermin D, which has been linked to alopecia and cancer, is required for the activation of inflammatory caspases, thereby regulating pyroptosis
156	CRIPSR-Cas9 -based CRISPR screens identify gasdermin D as a target for inflammatory caspases
157	GSDMD-independent and caspase-1-dependent pathways of pyroptosis.
158	Caspases-1 and caspase-4/5/11 release the autoinhibition on gasdermin-N to trigger pyroptosis
159	Caspase-4/5/11 cleave gasdermin D to unlock its intrinsic pyroptosis-inducing activity.
160	A specific dietary restriction, to L-methionine, results in a 30% longer life span of male Fischer 344 rats.
161	This paper provides an experimental basis for understanding the molecular basis of the effect of dietary restriction on the life span of animals.
162	Experiments on male Fischer 344 rats have shown that dietary methionine restriction is associated with a 30% extension of life span.
163	The biochemically well-defined pathways of methionine metabolism and utilization offer the potential for uncovering the precise mechanism(s) underlying this specific dietary restriction-related extension of life span.
164	Lifelong reduction in the concentration of a single dietary component, the essential amino acid L-methionine, from 0.86 to 0.17% of the diet results in a 30% longer life span of male Fischer 344 rats.
165	An experiment examining the effects of restricting a single component of the diet, the amino acid L-methionine, on the life span of male rats.
166	Lifelong dietary restriction of the amino acid methionine increases the life span of male rats
167	Lifelong reduction in the concentration of a single dietary component, the essential amino acid L-methionine, from 0.86 to 0.17% of the diet results in a 30% longer life span of male Fischer 344 rats.
168	Extending mammalian life span with a single dietary restriction
169	Extending life span using L-methionine restriction.
170	Drinking patterns may have important health implications.
171	Drinkers of wine outside meals exhibited higher death rates from all causes, noncardiovascular diseases, and cancer, as compared to drinkers of wine with meals.
172	Drinking outside meals may have important health implications.
173	Alcohol Consumption Patterns Are Associated With All-Cause and Specific-Cause Mortality in Men and Women
174	Drinkers of wine outside meals exhibited higher death rates from all causes, noncardiovascular diseases, and cancer, as compared to drinkers of wine with meals
175	Drinking patterns may have important health implications.
176	Drinkers of wine outside meals exhibited higher death rates from all causes, noncardiovascular diseases, and cancer.
177	Drinking patterns may have important health implications
178	Drinking patterns may have important health implications.
179	Drinking patterns may have important health implications
180	miR-302 regulates neurulation by suppressing neural progenitor expansion and precocious differentiation.
181	The mir-302 microRNA family regulates neurulation by suppressing neural progenitor expansion and precocious differentiation.
182	MicroRNA-302 has a critical role in regulating the onset of neurulation.
183	MicroRNA-Mir-302 family suppresses precocious differentiation in the neuroepithelium during mouse neurulation.
184	mir-302 regulates neuronal differentiation during neurulation.
185	microRNA-302 regulates neuronal differentiation in the mouse embryo
186	mir-302 modulates neurulation
187	The mir-302 microRNA family is expressed in the embryonic neuroepithelium and regulates neurulation by regulating neural progenitor expansion.
188	miR-302 regulates neurulation by controlling neural progenitor expansion and precocious differentiation.
189	The miR-302 microRNA family regulates neurulation.
190	Microlocalisation of neutrophils and CD8+ cells within the airway smooth muscle in smokers with COPD.
191	Microlocalisation of neutrophils and CD8+ cells in the airway smooth muscle in COPD.
192	Airway smooth muscle microinflammation in COPD.
193	Inflammatory cell microlocalisation in peripheral airway smooth muscle in smokers with COPD.
194	Neutrophilic and CD8+ Cell Infiltration in the Airway Smooth Muscle of Smokers with COPD
195	Neutrophils and CD8+ cells are microlocalised in airway smooth muscle in smokers with chronic obstructive pulmonary disease ( COPD )
196	Neutrophils and CD8+ cells localised within the airway smooth muscle of smokers with chronic obstructive pulmonary disease.
197	Smoking-induced airflow limitation is associated with neutrophilic infiltration in the airway smooth muscle.
198	Inflammatory cells localise to the airway smooth muscle in COPD.
199	Neutrophils and CD8+ cells infiltrate the airway smooth muscle in smokers with chronic obstructive pulmonary disease.
200	Barriers and facilitators to shared decision making for multidisciplinary sciatica care.
201	Barriers and facilitators to implementation of shared decision making in multidisciplinary sciatica care.
202	Barriers and facilitators for Shared Decision Making (SDM) in multidisciplinary sciatica care.
203	Barriers and facilitators for shared decision making in multidisciplinary sciatica care: a qualitative study.
204	Barriers and facilitators to shared decision making in multidisciplinary sciatica care: a qualitative study.
205	Barriers and facilitators to implementation of shared decision making in multidisciplinary sciatica care.
206	Barriers and facilitators for implementation of shared decision making in multidisciplinary sciatica care: a qualitative study.
207	Barriers and facilitators perceived for implementation of shared decision making in multidisciplinary sciatica care.
208	New barriers and facilitators for implementation of shared decision making in multidisciplinary sciatica care: a qualitative study.
209	Barriers and facilitators to implementation of shared decision making in multidisciplinary sciatica care.
210	No association between APH-1 sequence variations and Alzheimer's disease in a clinical sample.
211	The study suggests that polymorphisms in APH-1 coding regions are not linked with higher risk for sporadic AD in our Italian population sample.
212	The results of this study suggest that polymorphisms in APH-1 coding regions are not linked with higher risk for sporadic Alzheimer's disease in our Italian population sample.
213	Polymorphisms in APH-1 coding regions are not associated with sporadic Alzheimer's disease.
214	Associations of polymorphisms in APH-1a/b coding regions with Alzheimer's disease.
215	Variations in the coding regions of the anterior-pharynx defective-1 genes in AD do not seem to influence the risk for the disease.
216	The polymorphism of the APH-1 gene is not associated with Alzheimer's disease.
217	No evidence for association of APH-1 coding region variants with sporadic Alzheimer's disease in Italy.
218	Polymorphisms in APH-1a/b coding regions are not linked with higher risk for sporadic Alzheimer's disease.
219	This study investigated the association between APH-1 gene sequence polymorphisms and Alzheimer's disease in a sample of Italian individuals.
220	Trachoma is an unnecessary public health problem in Ayod County, Southern Sudan.
221	Trachoma in Ayod County, Jonglei State, Southern Sudan: the need for intervention activities
222	Trachoma is an unnecessary public health problem in Ayod.
223	Trachoma is an unnecessary public health problem in Ayod, Southern Sudan.
224	Trachoma is an unnecessary public health problem in Ayod.
225	Trachoma is an unnecessary public health problem in Ayod.
226	Trachoma is an unnecessary public health problem in Ayod.
227	Trachoma is an unnecessary public health problem in Ayod
228	Trachoma is an unnecessary public health problem in Ayod, Southern Sudan.
229	Trachoma is a serious public health problem in Ayod County, Southern Sudan
230	Foxk proteins are transcriptional repressors of autophagy
231	mTOR regulates autophagy by promoting transcription of Foxk1
232	Foxk proteins are transcriptional repressors of autophagy in muscle cells.
233	Foxk proteins are transcriptional repressors of autophagy
234	The transcription factor Foxk1/2 represses autophagy in response to nutrient deprivation.
235	Foxk proteins are transcriptional repressors of autophagy.
236	Autophagy is regulated by Foxk proteins via Sin3A-HDAC-dependent transcriptional control.
237	The transcription factors Foxk1/2 are direct transcriptional repressors of autophagy.
238	Foxk proteins are transcriptional repressors of autophagy in muscle cells and fibroblasts
239	Foxk proteins regulate autophagy by direct nuclear targeting in muscle cells and fibroblasts
240	Our study demonstrates that biologically relevant data can be harvested using such a multidisciplinary approach, and identifies new MAP complexes with potentially important roles in cell cycle regulation and mitosis.
241	Identification of novel microtubule-associated proteins reveals an integral role for microtubules in cell division.
242	This study identifies novel microtubule-associated proteins that may be important in regulating cell division.
243	Identifies novel MAP complexes in early Drosophila embryos with potential functions in mitosis.
244	Identification of novel microtubule-associated proteins in Drosophila using a multidisciplinary approach
245	A combined RNAi and bioinformatics approach reveals new microtubule-associated proteins involved in cell division.
246	Identification of novel MAP complexes with potential role in cell division and mitosis
247	By taking two complementary approaches to analyse the cellular function of novel MAPs isolated using this approach, we have identified and validated MAP complexes with potentially important roles in cell cycle regulation and mitosis.
248	We use a ribonuclease immunoprecipitation (RIP) screen to identify microtubule-associated proteins (MAPs) in early Drosophila embryos
249	We identify a set of microtubule associated proteins that may be involved in the regulation of cell cycle and mitosis.
250	Global prevalence of glaucoma: a systematic review and meta-analysis
251	Glaucoma is the leading cause of global irreversible blindness.
252	Global prevalence of glaucoma is 3.54%.
253	The global prevalence of glaucoma and projections of the number of affected people
254	Glaucoma is highly prevalent across the globe and projections of the number of cases for 2020 and 2040 show that in Africa the number of people affected will increase rapidly.
255	Glaucoma prevalence in people of African ancestry is highest.
256	Glaucoma is most prevalent in Africa
257	In the era of rising global populations, prevalence of glaucoma will continue to rise
258	Glaucoma is the leading cause of irreversible blindness worldwide.
259	The prevalence of glaucoma is high in Africa and increasing.
260	A transverse actin arc is induced by Arp2/3 complex inhibition in sea urchin coelomocytes
261	Pharmacological inhibition of the Arp2/3 complex in sea urchin coelomocytes drives an unusually broad cytoskeletal structure in cells with unusually broad lamellipodia
262	Arp2/3 complex inhibition in a broad LP region produces transverse actin arcs.
263	Using Light and Electron Microscopy, We Demonstrate that Arp2/3 Complex Inhibition via the Drug CK666 Dramatically Alters LP Actin Architecture, Slowed Centripetal Flow, and Induced a Novel Actin Structural Organization during Cell Spreading.
264	We hypothesize that the actin arcs made visible by Arp2/3 complex inhibition in coelomocytes may represent an exaggerated manifestation of the elongate mother filaments that could possibly serve as the scaffold for the production of the dendritic actin network.
265	Arp2/3 complex inhibition generates transverse actin arcs that form the scaffold for the production of the dendritic actin network.
266	Our results reveal that the Arp2/3 complex governs the formation of a unique phenotype that represents a morphological precursor of the dendritic actin network during cell spreading.
267	Arp2/3 complex inhibition induces a novel actin structural organization in lamellipodial cells.
268	The sea urchin coelomocyte acts as a model system to study the role of the Arp2/3 complex in the establishment and maintenance of the lamellipodial actin cytoskeleton.
269	.
270	The phenolic antioxidants epicatechin and chlorogenic acid activate survival/proliferation signals rather than inducing apoptosis in hepatoma cells.
271	Epicatechin and chlorogenic acid promote cell survival and inhibit apoptosis in a human hepatoma cell line.
272	(-)-Epicatechin and chlorogenic acid activate survival/proliferation pathways in a human hepatoma cell line ( HepG2 )
273	Epigallocatechin and chlorogenic acid modulate cell survival/proliferation and oxidative stress-mediated damage in HepG2 cells.
274	Phenolic compounds modulate cell signaling pathways associated with the regulation of the intrinsic tolerance to oxidative insults.
275	Phenols enhance the intrinsic cellular tolerance against oxidative insults in HepG2 cells.
276	Epigallocatechin and chlorogenic acid modulate intrinsic antioxidant defenses by activating survival/proliferation pathways in human hepatoma cells.
277	This work aimed to study the effect of (-)-epicatechin and chlorogenic acid on the regulation of apoptotic and survival/proliferation pathways in a human hepatoma cell line ( HepG2).
278	Phenolic compounds are unlikely to induce apoptosis in hepatocytes.
279	The dietary polyphenols ( -)-epicatechin and chlorogenic acid have no effect on apoptosis and enhance the intrinsic cellular tolerance against oxidative insults by activating survival/proliferation pathways.
280	Epitaxial passivation provides power conversion efficiencies of up to 6.6% for GaAs nanopillar-array photovoltaics.
281	Epitaxial passivation for GaAs nanopillar array photovoltaics.
282	Epitaxial Passivation of GaAs Nanopillar Array Photovoltaics with Air Mass 1.5 Global Power Conversion Efficiency of 6.63%.
283	GaAs nanopillar-array photovoltaics employing epitaxial passivation with air mass 1.5 global power conversion efficiencies of 6.63%.
284	Epitaxially grown radial InGaP shells cap III-V nanopillar-array-based solar cells to yield the first air mass 1.5 w cm-2 direct-bandgap nanoprism photovoltaic devices with a 6.63% global power conversion efficiency.
285	We report the first demonstration of GaAs nanopillar-array photovoltaics employing epitaxial passivation with air mass 1.5 global power conversion efficiencies of 6.63%.
286	III-V direct-bandgap semiconductor nanopillar arrays are epitaxially passivated to achieve high power conversion efficiencies
287	Epitaxial passivation of GaAs nanopillar-array photovoltaics.
288	We demonstrate 6.63% air mass 1.5 global power conversion efficiency in III-V nanopillar-array photovoltaics employing epitaxial passivation.
289	GaAs nanopillar-array photovoltaics with epitaxial passivation : a step toward commercialization.
290	Mice lacking neuropeptide Y demonstrate altered feeding response and behavioral phenotype.
291	Neuropeptide Y (NPY) Knockout Mice Have Reduced Food Intake in Response to Fasting.
292	Neuropeptide Y ( NPY ) plays a role in the regulation of food intake and the nociceptive system
293	This article provides evidence of involvement of NPY in energy balance, anxiety, and possibly nociception.
294	Neuropeptide Y is implicated in energy balance, anxiety, and nociception.
295	The data from these studies provide further evidence of involvement of NPY in energy balance, anxiety, and possibly nociception
296	Neuropeptide Y regulates food intake and anxiety-like responses.
297	Neuropeptide Y is a modulator of feeding, anxiety and pain.
298	In mice, the effects of NPY may be based on feeding or may be more peripherally related to nociception, anxiety, or stress.
299	The data from these studies provide further evidence of involvement of NPY in energy balance, anxiety, and possibly nociception.
300	Making emergency contraception more easily obtainable does no harm and may reduce the rate of unwanted pregnancies.
301	Making emergency contraception more easily obtainable does no harm and may reduce the rate of unwanted pregnancies
302	No harm and may reduce unwanted pregnancies in women with easy access to emergency contraception.
303	: Availability of emergency contraception does no harm, and it may reduce the rate of unwanted pregnancies.
304	Emergency contraception should be made easily obtainable for women.
305	In the emergency contraception study, it was found that women who had access to emergency contraception tended to use it more frequently.
306	The provision of emergency contraception without prescription does no harm and may reduce the risk of unintended pregnancy.
307	In the United States, women who wish to avoid pregnancy after a sexual encounter can be provided with emergency contraceptives obtained by a doctor without a prescription, but many women lack access to this contraception.
308	Access to emergency contraception by prescription is inconvenient.
309	Women can be given a supply of emergency contraception to keep at home.
310	Oxymetholone Therapy in Fanconi Anemia Improves Marrow Hematopoiesis in a Fancd2-/- Model
311	These results expand our knowledge of the regulation of hematopoietic stem cell proliferation and have direct clinical implications for the treatment of bone marrow failure.
312	Oxymetholone activates hematopoietic stem cells through a downregulation of osteopontin.
313	Androgens stimulate hematopoietic stem cell proliferation in a Fanconi mouse model.
314	Oxymetholone stimulates proliferation of hematopoietic stem and progenitor cells in Fancd2(-/-) mice
315	Oxymetholone in Adult Fancd2(-/-) Mice Increases the Proliferation of Hematopoietic Stem Cells in Response to Decreased Osteopontin
316	Oxymetholone increases the number of hematopoietic stem and progenitor cells in a Fancd2-deficient mouse model of bone marrow failure.
317	Oxymetholone modulates androgen-dependent hematopoietic stem cell biology.
318	Oxymetholone increases hematopoietic stem cell proliferation in Fanconi anemia
319	Oxymetholone enhances the proliferation of hematopoietic stem cells in aged Fancd2(-/-) mice
320	Macrophage responses to lipopolysaccharide are supported by a rapid and sustained glucose influx via GLUT1.
321	LPS accelerates glucose uptake in mouse macrophages.
322	Direct effects of lipopolysaccharide on glucose uptake by macrophages in vitro.
323	The effects of lipopolysaccharide on macrophages.
324	Macrophages consume and uptake glucose via GLUT1.
325	The direct effect of lipopolysaccharide on the uptake of glucose by macrophages is accelerated two- to threefold.
326	LPS uptake by macrophages is regulated by GLUT1 and is important for LPS toxicity.
327	A rapid and sustained glucose uptake by macrophages stimulated with lipopolysaccharide in vitro
328	Lipopolysaccharide stimulates the uptake of glucose by peritoneal macrophages in vitro.
329	Increased uptake of glucose by macrophages in response to endotoxemia is mediated by GLUT1 expression.
330	Fyn is a novel regulator of tumor progression
331	Integrin beta6 promotes oral cancer progression through the activation of the protein kinase Fyn
332	Activation of the integrin beta6-Fyn signaling cascade promotes oral cancer progression.
333	Integrin beta6 signaling activates Fyn and promotes oral cancer progression.
334	The integrin beta6 promotes oral cancer progression by activating Fyn through focal adhesion kinase
335	Integrin beta6 signaling activates Fyn and promotes oral cancer progression.
336	Integrin beta6 signaling activates Fyn and promotes oral cancer progression
337	This study demonstrates that the integrin beta6 activates Fyn and thereby promotes tumor progression.
338	Integrin beta6 signals to Fyn, activating Shc and promoting oral squamous cell carcinoma progression
339	Integrin beta6 signaling activates Fyn and promotes oral squamous cell carcinoma progression.
340	New enzymes may have potential to replace traditional methods for gene targeting in mammalian cells.
341	Zinc finger nucleases offer the promise of site-specific gene targeting to mammalian cells.
342	zinc finger nucleases show promise in improving the efficiency of gene targeting by introducing DNA double-strand breaks in target genes, which then stimulate the cell's endogenous homologous recombination machinery
343	Zinc finger nucleases offer an efficient and precise method of gene targeting
344	Zinc finger nucleases (ZFNs) offer a powerful tool for manipulating human and mammalian genomes.
345	The potential of zinc finger nucleases in gene targeting
346	Gene targeting represents a powerful new method for modifying the mammalian genome.
347	Zinc finger nucleases may enable efficient mammalian gene targeting
348	Zinc finger nucleases may be used to manipulate gene sequences in mammalian cells.
349	Zinc finger nucleases show promise in generating efficient gene targeting events.
350	CRTC2 contributes to gluconeogenesis, but not to blood glucose homeostasis.
351	CRTC2 is required for gluconeogenesis in vivo and promotes transcription of gluconeogenic genes in vivo.
352	The transcription factor CRTC2 contributes to transcriptional activation of the genes involved in hepatic gluconeogenesis.
353	CRTC2 mediates transcriptional activation of gluconeogenic genes.
354	CRTC2-deficient mice display reduced glucose production in response to glucagon.
355	The cAMP response element-binding protein (CREB) is a major regulator of hepatic response to fasting.
356	CRTC2 promotes fasting response through a transcriptional response involving PGC-1alpha and Gluconeogenic genes in vivo.
357	Reduced gluconeogenic response in CRTC2 mutant hepatocytes.
358	CRTC2 is a transcription coactivator for the CREB-dependent regulation of hepatic gene expression in vivo.
359	CRTC2 modulates transcription of hepatic gluconeogenic genes in response to glucagon.
360	The human zinc finger protein ZFP57 binds a methylated target sequence by alternating between two Cys2His2 zinc finger domains and thereby modulates PLAGL1 gene expression.
361	Mutations and hypomethylation of the TNDM1 ICR both associated with Transient Neonatal Diabetes Mellitus type 1 result in loss of hZFP57 binding to the TNDM1 locus, likely causing PLAGL1 activation
362	The TNDM1 ICR and hZFP57 interact through the third and fourth zinc finger domains in human
363	The Cys2His2 zinc finger protein ZFP57 binds to the hypomethylated TNDM1 ICR and PLAGL1 locus.
364	hZFP57 is an unusual zinc finger protein which binds the TNDM1 ICR through the third and the fourth zinc finger domains and is associated with Transient Neonatal Diabetes Mellitus type 1.
365	Identification of DNA binding site of ZFP57: a potential new candidate gene in diabetes
366	ZFP57 recognizes the methylated CGC TGC(met)CGC target sequence.
367	Molecular mechanisms of repressive gene regulation in ZFP57-associated TNDMT1 disease.
368	The six Cys2His2 zinc finger domains of human ZFP57 recruits hZFP57 to its target DNA through distinct sequences.
369	hZFP57 recognizes the methylated TGC(met)CGC target sequence through the third and fourth zinc finger domains.
370	Diabetes drugs: glitazones and gliptins associated with risk of major adverse events in type 2 diabetes
371	Gliptin and glitazone use is associated with increased risks of severe kidney failure
372	The risk of severe kidney failure increased with metformin monotherapy when glitazones and gliptins were prescribed together.
373	Gliptins and glitazones reduce the risk of blindness in patients with type 2 diabetes.
374	The results suggest that, compared with metformin monotherapy, dual therapy involving metformin and either gliptins or glitazones is associated with a significant reduction in the risk of hyperglycaemia, especially when metformin is used in combination with gliptins or glitazones.
375	Gliptins are associated with a reduced risk of hypoglycaemia in type 2 diabetes patients.
376	This study provides evidence that glitazone and gliptin monotherapy are associated with increased risks of severe kidney failure, hypoglycaemia, and blindness.
377	Dual therapy involving metformin with either gliptin or glitazones is associated with lower risks of hyperglycaemia.
378	The use of glitazones and gliptins is associated with the risks of hyperglycaemia and hypoglycaemia.
379	Hypoglycaemic therapy reduces risk of blindness and hypoglycaemia in patients with type 2 diabetes
380	MicroRNAs modulate tumorigenesis via non-coding RNA.
381	A non-coding fragment of mRNA can lower the steady state expression of mature miRNA and decrease tumor growth in cancer cells.
382	A 3'UTR fragment can be used to modulate microRNA functions, thereby affecting the development of breast cancer.
383	Non-coding mRNA 3'UTRs modulate the functions of microRNAs and may act as anti-tumor agents.
384	A 3'UTR fragment binds and modulates miRNA activities in a mouse breast carcinoma cell line, 4T1.
385	Expression of non-coding mRNA fragment can lower mature microRNA levels and consequently decrease tumorigenesis.
386	Expression of a 3'UTR fragment can be used to modulate miRNA activities, thereby influencing cellular functions and disease processes
387	3'UTR Fragments of non-coding mRNA Modulate MicroRNA Functions in Cancer Cells.
388	MicroRNAs are modulated by a non-coding 3'UTR of the versican gene in breast carcinoma.
389	3'UTR fragments modulate miRNA expression and may therefore be used to modulate the progression of cancer.
390	Sub-Saharan African-trained physicians comprise most of the physician workforce in the United States.
391	Migration trends among SSA-trained physicians found in the physician workforce of the United States.
392	SSA-trained physicians represent the largest group of physicians born or trained in Sub-Saharan Africa currently practicing in the United States.
393	Physician migration from sub-Saharan Africa to the United States has increased in recent years.
394	The United States Is A Leading Destination For Emigrating Physicians From Sub-Saharan Africa
395	Emigration of physicians from sub-Saharan Africa to the United States
396	The current emigration trends of sub-Saharan Africa (SSA) physicians found in the physician workforce of the United States.
397	Physician emigration from sub-Saharan Africa to the United States is increasing for most SSA source countries.
398	Migration of Physicians from Sub-Saharan Africa to the United States
399	Physician Emigration from Sub-Saharan Africa to the United States.
400	Multiple DAF-12 activities influence life span in distinct ways in contexts of reduced DAF-2/InsR signaling.
401	Multiple DAF-12 Activities Influence Lifespan in the Context of Reduced DAF-2/InsR Signaling
402	Multiple DAF-12 activities influence life span in distinct ways in contexts of reduced DAF-2/InsR signaling
403	Differential Effects of Unliganded and Ligand-Derived DAF-12 on Life Span in the Nematode Caenorhabditis elegans
404	Multiple DAF-12 activities influence life span in distinct ways in contexts of reduced DAF-2/InsR signaling.
405	Signaling interactions among bile acid-like steroid hormones, DAF-12, and DAF-2/InsR signaling in Caenorhabditis elegans
406	The conserved nuclear receptor DAF-12 acts in opposition to DAF-2/InsR signaling to control longevity
407	DAF-12 regulates life span by modulating DAF-2/InsR signaling.
408	DAF-12 liganding and unliganding regulate life span in Caenorhabditis elegans
409	In the nematode Caenorhabditis elegans, steroid hormones known as dafachronic acids influence longevity by binding to and regulating the activity of the conserved nuclear receptor DAF-12, and the insulin receptor (InsR) ortholog DAF-2 controls life span by inhibiting the FoxO transcription factor DAF-16.
410	Morin alleviates airway inflammation in chronic asthma by modulation of oxidative stress
411	Morin attenuates airway inflammation in asthma by inhibiting oxidative stress and activating nitric oxide synthase/selenoprotein phosphatase/mitogen-activated protein kinase/extracellular signal-regulated kinase pathways.
412	Morin alleviates airway inflammation in chronic asthma through modulation of reactive oxygen species/mitogen-activated protein kinase.
413	Morin alleviates airway inflammation in chronic asthma with an emphasis on oxidative stress modulation.
414	Morin alleviates airway inflammation in asthma through a ROS-dependent mechanism.
415	Morin modulates proinflammatory gene expression and cytokine responses by modulation of oxidative stress in the airways of asthma.
416	Morin alleviates airway inflammation and inflammation in a model of chronic asthma through oxidative stress modulation.
417	Morin ameliorates airway inflammation in chronic asthma via modulation of reactive oxygen species and mitogen-activated protein kinase.
418	Morin modulates inflammatory responses by attenuating reactive oxygen species generation.
419	The anti-inflammatory effects of morin on asthma through the suppression of oxidative stress-related events.
420	The RNAi kinome library identifies novel and essential proteins kinases that regulate the bloodstream to procyclic form transition in Trypanosoma brucei.
421	An RNAi kinome library is generated identifying novel protein kinase regulatory networks that control bloodstream to procyclic form differentiation.
422	Trypanosoma brucei has two novel protein kinases involved in the regulation of differentiation.
423	The identification of a RNAi kinome library in Trypanosoma brucei provides a valuable asset for elucidating signalling pathways and the role of kinases in cell cycle regulation and differentiation
424	RNAi screen identifies novel kinase targets in Trypanosoma brucei.
425	Identification and characterization of protein kinases involved in the regulation of cell cycle and differentiation in African trypanosomes
426	Identifying kinase repressors of differentiation in Trypanosoma brucei using RNAi.
427	This work established an inducible cell line library, termed an RNAi kinome, for the first time identifying novel protein kinase activity involved in cell cycle regulation and differentiation in Trypanosoma brucei.
428	The study uncovers two trypanosome kinases involved in regulating cellular differentiation between bloodstream and procyclic forms
429	The African trypanosome has 190 predicted protein kinases.
430	There is some evidence that type 1 diabetes is associated with the composition of the gut microbiome.
431	The gut microbiome may be a key factor in type 1 diabetes risk.
432	Recent studies suggest that a gut microbiome may play a key role in the development of type 1 diabetes.
433	The gut microbiome plays an important role in type 1 diabetes.
434	Gut microbiota are involved in autoimmunity.
435	The gut microbiome may play a role in the development of autoimmune type 1 diabetes.
436	The gut microbiome plays an important role in the pathogenesis of autoimmune diseases
437	Type 1 diabetes may be partially regulated by gut microbes
438	The microbiome has a strong impact on the development of type 1 diabetes.
439	The gut microbiome may influence the development of type 1 diabetes.
440	CCP4 is a collection of programs and associated data and software libraries that can be used for macromolecular structure determination by X-ray crystallography.
441	The CCP4 software suite is a collection of programs and associated data and software libraries which can be used for macromolecular structure determination by X-ray crystallography.
442	The CCP4 software suite is a collection of programs and associated data and software libraries which can be used for macromolecular structure determination by X-ray crystallography.
443	The CCP4 software suite is a collection of programs and associated data and software libraries which can be used for macromolecular structure determination by X-ray crystallography.
444	The CCP4 software suite is a collection of programs and associated data and software libraries which can be used for macromolecular structure determination by X-ray crystallography.
445	The CCP4 software suite is a collection of programs and associated data and software libraries which can be used for macromolecular structure determination by X-ray crystallography.
446	CCP4 is a collection of programs and associated data and software libraries which can be used for macromolecular structure determination by X-ray crystallography.
447	Structure solution by macromolecular crystallography is becoming increasingly automated and the CCP4 suite includes several automation pipelines.
448	The CCP4 suite is a collection of programs and associated data and software libraries that can be used for macromolecular structure determination by X-ray crystallography.
449	The CCP4 suite is a collection of programs and associated data and software libraries which can be used for macromolecular structure determination by X-ray crystallography.
450	Dynamic microtubules and dynein at the cortex are functionally associated and are able to position microtubules in vitro.
451	Dynein at the cortex interacts with dynamic microtubule ends to regulate microtubule dynamics and drive positioning processes in living cells
452	Reconstitution of the cortical microtubule-dynein interactions in an in vitro system reveals the intrinsic ability of dynein-dynein interactions to regulate microtubule dynamics and drive positioning processes in living cells.
453	Dynein-dependent positioning is driven by force production at microtubule ends.
454	Dynein interacts with microtubule ends to generate forces and stabilize asters.
455	Dynein pulls microtubule asters to position them.
456	Dynein-Mediated Pulling Forces Regulate Microtubule Dynamics and Positioning Processes in Living Cells.
457	The results demonstrate the intrinsic ability of cortical microtubule-dynein interactions to regulate microtubule dynamics and drive positioning processes in living cells.
458	Dynein -microtubule end interaction generates a pulling force that can drive microtubule aster positioning in vitro.
459	Dynein-Microtubule Interactions drive Microtubule Stability and Positioning in Living Cells
460	High-throughput mapping identifies 50 cellular factors required for positioning of genomic regions at the cellular scale
461	HIPMap identifies a compendium of cellular factors involved in spatial genome organization.
462	HIPMap is a method for mapping the spatial location of genomic regions at large scale.
463	Large-scale mapping of genome positions reveals the importance of chromosome replication for proper gene positioning
464	We developed HIPMap, a high-precision, high-throughput, automated fluorescent in situ hybridization imaging pipeline, for mapping of the spatial location of genome regions at large scale.
465	This study established a method for the large-scale mapping of genome locations and identified cellular factors required for correct positioning of a set of functionally diverse genomic loci.
466	Spatial genomic organization is controlled by a diverse set of cellular factors.
467	High-throughput imaging position mapping (HIPMap) enabled an unbiased siRNA screen for factors involved in genome organization in human cells.
468	We identify cellular factors required for the correct positioning of a diverse set of genomic loci.
469	HIPMap reveals cellular factors involved in genome organization in human cells
470	Smoking reduction by 50% significantly reduces the risk of lung cancer.
471	Smoking reduction by 50% reduces lung cancer risk among heavy smokers
472	Smoking reduction by 50% is associated with a reduced risk of lung cancer.
473	Reduction in smoking frequency is associated with lower risk of lung cancer
474	Smoking reduction reduces the risk of lung cancer.
475	Smoking reductions of 50% reduce the risk of lung cancer.
476	Among individuals who smoke 15 or more cigarettes per day, smoking reduction by 50% significantly reduces the risk of lung cancer.
477	Reducing smoking to less than 15 cigarettes per day decreases the risk of lung cancer.
478	Smoking reduction by 50% significantly reduces the risk of lung cancer among individuals who smoke 15 or more cigarettes per day.
479	Reducing the number of cigarettes smoked by 50 percent reduces the risk of lung cancer.
480	Rab5-to-Rac trafficking circuitry controls the morphology of motile cells.
481	Rac activation occurs on early endosomes, where the RacGEF Tiam1 is also recruited.
482	Rac signaling is limited to the membrane.
483	Rac activation is regulated by Rab5 endocytosis and recycling to the plasma membrane.
484	The Rab5-to-Rac circuitry coordinates endocytosis and Rac activation to regulate cell migration.
485	Membrane Trafficking of Rac Is Required for the Spatial Resolution of Rac-Dependent Motogenic Signaling.
486	A Rab5-Rac circuitry controls the morphology of motile cells.
487	The Rab5-to-Rac circuitry controls the morphology of tumor cells and primordial germinal cells during zebrafish development.
488	Rab5-dependent endocytosis promotes Rac signaling.
489	Rac-dependent protrusion formation is regulated by endosomal membrane trafficking
490	Epidermal VEGF promotes tumor cell proliferation by a cell-autonomous and angiogenesis-independent mechanism.
491	VEGFR-EGFR synergize to promote tumor growth.
492	VEGF upregulates Flt1, a potent cell-autonomous growth factor in skin tumors.
493	VEGFR and EGFR synergize in neoplastic cells to promote tumor growth.
494	The data show that in addition to its function as an angiogenesis-promoting growth factor, VEGF is a potent cell-autonomous promoter of tumor cell proliferation.
495	Autocrine VEGF regulates tumor cell proliferation and angiogenesis in K5-SOS-dependent mouse skin tumors.
496	K5-SOS-dependent mouse skin tumors upregulate VEGF, Flt1, and Neuropilin-1 in a signaling loop involving EGFR
497	Epidermal VEGF, Flt1, and Neuropilin-1 Synergize with EGFR to Promote Tumor Growth
498	Autocrine VEGF promotes tumor growth in a cell-autonomous and angiogenesis-independent manner.
499	Autocrine VEGF promotes epidermal tumor growth and inhibition of VEGFR-EGFR signaling leads to tumorigenesis.
500	Upon being freed of its inhibitor Gal80 by the action of galactose, Gal4 quickly recruits SWI/SNF to the genes, and that nucleosome "remodeler" rapidly removes promoter nucleosomes.
501	The universal transcriptional activator Gal4 removes promoter nucleosomes as it triggers transcription, but how it does so has remained obscure.
502	Activation and repression of gene expression involve two distinct chromatin remodelling pathways
503	Two routes to nucleosome removal and activation of transcription.
504	The universal transcriptional activator Gal4 removes promoter nucleosomes as it triggers transcription, but how it does so has remained obscure.
505	The repressor Gal4 recruits SWI/SNF to remove promoter nucleosomes, a process that enables transcriptional activation.
506	We show that inactivation of Gal4 has two effects, one of which is to recruit SWI/SNF, an enzymatic chromatin "remodeler," to the promoter, and a second of which is to block nucleosomes from forming in the region of the promoter.
507	The universal transcriptional activator Gal4 removes promoter nucleosomes as it triggers transcription, but how it does so has remained obscure.
508	Nucleosome removal is required for activation of transcription in yeast
509	The universal transcriptional activator Gal4 removes promoter nucleosomes as it triggers transcription, but how it does so has remained obscure.
510	Alendronate treatment for osteoporosis: a randomized, double-blind study
511	Alendronate Increases Bone Density and Bone Health Over 10 Years.
512	Alendronate is a bone-building agent with prolonged effects.
513	Alendronate treatment has long-term effects on bone mineral density.
514	Treatment with 10 mg of alendronate daily for 10 years produced mean increases in bone mineral density of 13.7 percent at the lumbar spine ( 95 percent confidence interval, 12.0 to 15.5 percent ), 10.3 percent at the trochanter ( 95 percent confidence interval, 8.1 to 12.4 percent ), and 6.7 percent at the total proximal femur ( 95 percent confidence interval, 4.4 to 9.1 percent ) as compared with base-line values; smaller gains occurred in the group given 5 mg daily.
515	The results of the ALDROSS (A Multinational Long-term Evaluation of Alendronate to Prevent Osteoporosis and Related Fractures in Women) study suggest that alendronate provides effective and sustained bone-protective benefits in postmenopausal women.
516	The therapeutic effects of alendronate were sustained and the drug was well tolerated over a 10-year period.
517	Alendronate is a therapeutically effective treatment for osteoporosis and its therapeutic effect is sustained over 10 years.
518	Effect of long-term alendronate treatment on bone mineral density and biochemical markers of bone remodeling in women with osteoporosis.
519	Alendronate treatment for 10 years in postmenopausal women results in sustained increases in bone mineral density.
520	This series of studies describes the development of a measure of emotional intelligence based on the model of emotional intelligence developed by Salovey and Mayer.
521	Emotional intelligence is a valid and reliable construct.
522	The development and validation of a scale of emotional intelligence.
523	The 33-item measure of emotional intelligence is valid, reliable, and associated with other psychological traits
524	The development and validation of a measure of emotional intelligence.
525	Emotional Intelligence Is Associated with Emotional Skills and Personality
526	The measure of emotional intelligence is sensitive to a number of theoretically related constructs.
527	The development of a measure of emotional intelligence.
528	The 33-item measure correlates with theory related constructs and relates to personality dimensions.
529	The development of a measure of emotional intelligence.
530	There is a growing body of evidence supporting the notion that malignant tumors are heterogeneous and contain diverse subpopulations of cells with unique characteristics including the ability to initiate a tumor and metastasize.
531	Malignant tumors are heterogeneous and contain diverse subpopulations of cells with unique characteristics.
532	Cancer stem cells: targets for novel therapies in gastrointestinal malignancies.
533	Cancer stem cells as potential targets for anticancer therapy
534	The so-called cancer stem cell ( CSC ) theory posits that a small population of cancer cells has the potential to be the origin of most cancers.
535	Therapeutic approaches against gastrointestinal malignancies have a great potential to improve patient outcomes.
536	Targeting cancer stem cells is important for successful cancer treatment.
537	The development of novel therapeutic approaches against the underlying population of cells that maintains the tumorigenic potential of a tumor is a key element to overcome the therapeutic failure associated with the cancer disease.
538	New therapeutic strategies are needed to address the unmet medical needs associated with gastrointestinal cancer stem cells.
539	New treatment strategies are needed to improve therapeutic outcomes in gastrointestinal malignancies.
540	Growth inhibitors such as TGF-beta may alter the cell's response to growth-stimulating factors.
541	Long-term exposure of rat heart endothelial cells to TGF-beta induces dramatic changes in morphology that are characteristic of senescent cells.
542	Inhibitors of the growth of cells are capable of inhibiting the response to growth stimulators in cells.
543	TGF-beta decreases the number of high-affinity growth factor receptors.
544	Treatment of endothelial cells with transforming growth factor-beta decreases the number of growth-stimulating growth factor receptors.
545	TF-beta decreases the number of high-affinity receptors for growth-stimulating factors and alters the expression of specific competence genes.
546	Long-term exposure of rat heart endothelial cells to TGF-beta also induces dramatic changes in morphology that are characteristic of senescent cells.
547	Transforming growth factor-beta is an inhibitor of the proliferation and migration of endothelial cells and also has the ability to induce endothelial cell senescence.
548	Transforming growth factor-beta treatment decreases the number of high-affinity receptors for epidermal growth factor.
549	The effect of growth factors on cells is complex.
550	Long non-coding RNAs are involved in cellular responses to environmental stresses
551	Short-lived long non-coding RNAs respond to cellular stresses
552	Molecular response to chemical stresses is mediated by short-lived long ncRNAs.
553	Novel, short-lived, long non-coding RNAs respond to chemical stresses.
554	The molecular response to stress involves elaborate modulation of gene expression and is of homeostatic, ecological, and evolutionary importance.
555	Novel short-lived long non-coding RNAs that respond to chemical stressors.
556	Short-lived long non-coding RNAs respond to general and specific chemical stresses
557	Long non-coding RNAs (ncRNAs) respond to general and specific chemical stressors.
558	Short-lived Long Non-coding RNAs Respond to Chemical Stressors
559	The RNA landscape of the cell.
560	LAR expression is T lineage specific within the murine hemopoietic system.
561	Expression of LAR is restricted to the T cell lineage.
562	Expression of LAR, a T cell lineage specific tyrosine phosphatase, is regulated during differentiation of the murine B lineage.
563	LAR is a T cell lineage specific receptor-type tyrosine phosphatase.
564	Expression of LAR is lineage specific within the murine hematopoietic system.
565	LAR is a T lineage-specific receptor-type tyrosine phosphatase
566	Expression of LAR in murine T cells is developmentally regulated.
567	LAR is a T cell lineage-specific, developmentally regulated receptor-type tyrosine phosphatase.
568	LAR is a T cell lineage-specific tyrosine phosphatase
569	The expression of LAR is restricted to the T cell lineage.
570	Progress has been so rapid in T-cell-antigen recognition that it might be the first system in which the molecular basis of cell–cell recognition is understood
571	A key step in understanding T-cell-antigen recognition is to understand the signalling pathways that regulates it.
572	T-cell-antigen recognition may be the first system in which the molecular basis of cell–cell recognition is understood.
573	Progress has been so rapid in the area of T-cell-antigen recognition that it might be the first system in which the molecular basis of cell-to-cell recognition is understood.
574	Recent advances in t-cell research have revealed a molecular basis for antigen–T-cell recognition.
575	T-cell recognition is the first system in which the molecular basis of cell-to-cell recognition is understood.
576	Advances have been made in our understanding of how T-cells recognize their antigens and how they identify and respond to the antigens of other cells.
577	Progress has been so rapid that T-cell-antigen recognition might be the first system in which the molecular basis of cell-to-cell recognition is understood.
578	Progress in the understanding of how the immune system works has led to a much clearer understanding of cell–cell interactions.
579	T-cell-antigen recognition might be the first system in which the molecular basis of cell–cell recognition is understood.
580	Microstructural changes in the white matter of the right superior frontal gyrus are associated with late-life depression.
581	Lower fractional anisotropy values in the white matter of the right superior frontal gyrus are associated with late-life depression.
582	Microstructural changes in the white matter of the right superior frontal gyrus are associated with late-life depression.
583	White Matter Microstructure Is Associated With Late-Life Depression
584	Microstructural abnormalities in the white matter of the dorsolateral prefrontal cortex are associated with late-life depression.
585	This study provides the first neuroimaging evidence that microstructural changes in the white matter of the dorsolateral prefrontal cortex are associated with late-life depression.
586	Microstructural changes in the white matter of the right superior frontal gyrus are associated with late-life depression.
587	Microstructural changes in the white matter of the right superior frontal gyrus are associated with late-life depression.
588	White Matter Microstructure Is Associated With Late-Life Depression.
589	Microstructural changes in the white matter of the right superior frontal gyrus are associated with late-life depression.
590	The regulation of self-ligand expression on natural killer cells and some T cells
591	Receptors for the activation of natural killer (NK) cells are found on NK cells and some T cells.
592	NK cells use self-encoded ligands to target NK-cell specific self-destructive pathways
593	Understanding how the regulation of self-encoded ligand expression is regulated may provide novel avenues for future therapeutic approaches to infections and cancer.
594	The regulation of natural killer cell ligands
595	Self-Encoded Ligands for Natural Killer Cell Activating Receptors
596	A review of the regulation of ligands for activating natural killer (NK) and T lymphocyte receptors.
597	Natural killer cells bind to ligands that can be recognized by activating receptors.
598	The regulation of ligand-encoded ligands on natural killer (NK) cells and T cells provides new avenues for immune tolerance.
599	Recombinant ligands for natural killer cells.
600	New insight into the functions of candidate susceptibility genes for human schizophrenia.
601	Disrupted-in-schizophrenia 1 (DISC1) and neuregulin 1 (NRG1) function in parallel neurodevelopmental pathways
602	Functional connections between two candidate schizophrenia susceptibility genes in the zebrafish.
603	Disrupted-in-schizophrenia 1 and neuregulin 1 function in common pathways controlling oligodendrocyte and neuronal development in the zebrafish embryo.
604	Disc1 and NRG1 regulate cerebellar neuron and oligodendrocyte development in zebrafish.
605	Loss of olig2 expression is required for normal development of oligodendrocytes and neurones.
606	These findings suggest that disc1 and nrg1 function in common or related pathways controlling development of oligodendrocytes and neurones from olig2-expressing precursor cells.
607	We use zebrafish as a model organism to provide novel insights into the roles of DISC1 and NRG1 in brain development.
608	Genetic interactions between candidate susceptibility genes for schizophrenia are revealed in the zebrafish embryo.
609	Insights from the development of the zebrafish brain suggest that the susceptibility genes disc1 and nrg1 function in common or related pathways controlling development of oligodendrocytes and neurones.
610	Macrophages are a diverse population that must have different roles at steady state and during inflammation.
611	Differentiation of resident and newly recruited tissue macrophages during inflammation is regulated by tissue niche versus ontological origin
612	A tissue's unique composition of embryonically and adult-derived macrophages dictates the roles they play during homeostasis and disease
613	Embryonic and adult-derived macrophages have distinct roles in adult tissues.
614	Recent insights about the biology of circulating monocytes and tissue-resident macrophages.
615	The tissue niche versus ontological origin of resident and new macrophages in the steady state.
616	This review discusses the diverse origins of macrophages and their contribution to the immune system.
617	Tissue niche and ontological origin regulate the functional properties of tissue macrophages
618	Macrophages of diverse origins play distinct roles during homeostasis and inflammation.
619	Tissue macrophages are multilineage and not circulating monocytes.
620	Correction of a gene-splicing mutation reverses premature aging symptoms in human fibroblasts.
621	An efficient cellular cure for Hutchinson-Gilford progeria syndrome is possible by restoring normal splicing of lamin A mRNA
622	Genetic correction of the splicing event in lamin A reveals that cellular aging can be corrected in cells from individuals with Hutchinson-Gilford progeria syndrome.
623	Correction of the aberrant splice site can be used to reverse the nuclear aging defects seen in Hutchinson-Gilford progeria syndrome.
624	Splicing correction of mutated LMNA restores nuclear envelope architecture in patients with Hutchinson-Gilford progeria syndrome.
625	The splicing defect in HGPS fibroblasts can be corrected, restoring normal nuclear envelope architecture, normal histone modifications, and correcting the phenotypic features of premature aging
626	The cellular disease phenotype is reversible in cells from individuals with Hutchinson-Gilford progeria syndrome.
627	Correction of the aberrant splicing event in lamin A causes rescue of the nuclear envelope of fibroblasts from individuals with Hutchinson-Gilford progeria syndrome.
628	Using targeted correction of an aberrant cryptic splice site, we demonstrate that cellular disease symptoms in Hutchinson-Gilford progeria syndrome can be rescued.
629	Correction of the aberrant splicing event in LMNA pre-mRNA rescues cellular pathology in fibroblasts from individuals with Hutchinson-Gilford progeria syndrome.
630	Oxytocinase subfamily of amimopeptidases in pregnancy, memory retention and antigen presentation
631	Oxytocinase subfamily of M1 family of amimopeptidases are localized in endoplasmic reticulum.
632	Oxytocinase subfamily: a new family of enzymes.
633	A new family of M1 oxytocinases.
634	Oxytocinase Subfamily of Aminopeptidases.
635	The M1 family of aminopeptidases has a distinct subfamily of 3 enzymes, termed "Oxytocinase subfamily".
636	Oxytocinase Subfamily of Aminopeptidases: Molecular Biology and Pathophysiology
637	The members of the "Oxytocinase" subfamily belong to a distinct group of M1 family of amimopeptidases.
638	Oxytocinase subfamily of M1 amimopeptidases
639	Oxytocinase-like amimopeptidases represent a newly identified group of amimopeptidases with distinctive localization and enzymatic activity.
640	Rho proteins interact with adherens junctions in the regulation of cytoskeletal organisation.
641	Rho signalling in cell adhesion
642	Rho small GTPases are involved in the coordination of adherens junctions and the underlying cytoskeleton.
643	The adhesion system is regulated by Rho-family proteins.
644	Signalling and cytoskeletal interactions at the cell surface play an important role in regulating cell adhesion.
645	The adhesion of cells to their environment is largely achieved by means of a network of proteins called adherens junctions.
646	The adhesion of cells is tightly regulated by signalling from Rho proteins.
647	An understanding of the dynamics of the Rho protein Rho kinase and the regulation of its activity by the Ras family of GTPases provides a powerful mechanism to control adhesion.
648	Rho proteins modulate the formation and function of adherens junctions.
649	The Rho family of small GTPases are able to modulate the assembly and regulation of adherens junctions.
650	RTK inhibitors have a role in inhibiting tumor growth by inhibiting angiogenesis.
651	These compounds display dose-dependent anti-angiogenic and anti-tumor efficacies when paired with photodynamic therapy.
652	RTK inhibitors, PD173074 and PD166285, are able to inhibit tumor cell growth and angiogenesis in vivo and are able to enhance photodynamic therapy-induced tumor regressions.
653	The inhibitors of angiogenic growth factor receptors, PD166285 and PD173074, prolong tumor regression following photodynamic therapy.
654	RTK inhibitors PD166285 and PD173074 induce prolonged tumor regressions in combination with photodynamic therapy.
655	PD166285 and PD173074 demonstrate anti-angiogenic activity and anti-tumor efficacy in combination with photodynamic therapy.
656	Combination of broad-spectrum and selective FGFR1 tyrosine kinase inhibitors with photodynamic therapy results in prolonged anti-tumor efficacy.
657	Combination of a tyrosine kinase inhibitor with photodynamic therapy provides significant antitumor activity.
658	Inhibition of angiogenic growth factors with PD166285, a broad-spectrum receptor tyrosine kinase inhibitor, or PD173074, a selective FGFR1 tyrosine kinase inhibitor, results in a prolonged tumor regression following photodynamic therapy.
659	Anti-angiogenic activities of PD166285, a broad-spectrum RTK inhibitor, and PD173074, a selective FGFR1TK inhibitor, in combination with photodynamic therapy.
660	A novel mechanism for angiopoietin-1-induced endothelial barrier protection.
661	Angiopoietin-1 prevents vascular permeability through coordination of p190 RhoGAP and Rac1
662	Angiopoietin-1 prevents vascular permeability by regulating the endothelial cytoskeleton through coordinated and opposite effects on the Rho GTPases Rac1 and RhoA.
663	RhoGAP regulates cytoskeleton dynamics in endothelium to inhibit vascular leak
664	By regulating Rho family GTPases, Ang-1 prevents endothelial permeability in response to endotoxin.
665	Ang-1 protects against endotoxemia through coordinated regulation of the endothelial cytoskeleton.
666	Angiopoietin-1 inhibits vascular permeability by regulating the endothelial cytoskeleton.
667	Ang-1 inhibits vascular permeability by regulating the endothelial cytoskeleton through coordinated and opposite effects on the Rho GTPases Rac1 and RhoA
668	Ang-1 signaling controls endothelial junctions in vivo.
669	Rho family GTPase regulation of the endothelial cytoskeleton is critical for the anti-permeability effects of angiopoietin-1.
670	The minimal region required for efficient ARS activity is composed of two types of genetic elements.
671	The minimal ARS element of the fission yeast Schizosaccharomyces pombe is composed of two general types of genetic elements
672	First structural analysis of an autonomously replicating sequence element of Schizosaccharomyces pombe identifies a critical region for ARS activity within a much larger region.
673	We report the first fine-structure analysis of an ARS element in the fission yeast Schizosaccharomyces pombe.
674	Analysis of a minimal fission yeast autonomously replicating sequence identifies a critical 50 bp segment as the only genetic element necessary for efficient ARS activity.
675	An ARS element in the fission yeast Schizosaccharomyces pombe comprises two regions of DNA.
676	ARS elements consist of a 50 bp segment that is absolutely required for efficient ARS activity.
677	The minimal ARS element of the fission yeast Schizosaccharomyces pombe is surprisingly large.
678	The fine structure of an autonomously replicating sequence.
679	The minimum structure of an ARS element defines a segment that is absolutely required for efficient ARS activity.
680	Adjuvant therapy is important in the treatment of high grade prostate cancer.
681	Among patients with a Gleason score of 8 or greater, pT2, preoperative PSA and pathological grade are the most significant independent predictors of progression-free survival after radical prostatectomy, and all are associated with cancer specific survival.
682	The long-term survival of high grade prostate cancer after radical prostatectomy.
683	Survival after radical prostatectomy for pathologically high grade prostate cancer.
684	A randomized trial evaluating the long-term outcomes after radical prostatectomy for high-grade prostate cancer.
685	Adjuvant treatment, stage, preoperative PSA, and pathological grade are significant predictors of progression-free survival in men with pathological Gleason 8 or greater prostate cancer.
686	High grade prostate cancer can be controlled with radical prostatectomy in some patients.
687	The pathological stage is important in determining the outcome of radical prostatectomy and adjuvant treatment.
688	Prostate cancer.
689	Patients with pathological Gleason score 8 or greater prostate cancer can be controlled with radical prostatectomy if disease is confined pathologically.
690	Acupuncture combined with auricular point sticking improves post stroke depression.
691	Auricular point sticking combined with acupuncture can be used to treat post stroke depression.
692	Acupuncture combined with auricular point sticking is superior to western medication in the treatment of poststroke depression.
693	auricular point sticking has good effect on post stroke depression.
694	Combination therapy of acupuncture and auricular point pressing may improve post stroke depression.
695	Acupuncture combined with auricular point sticking has better effects on post stroke depression than western medication treatment.
696	Acupuncture combined with auricular point sticking therapy is clinically effective for post stroke depression.
697	Acupuncture combined with auricular point sticking can improve the clinical effect of post stroke depression.
698	Acupuncture combined with auricular point sticking improves depression in post stroke patients.
699	Acupuncture combined with auricular point sticking can improve clinical depression and side effects of antidepressants.
700	Suppression of Ox-LDL-induced Macrophage Proliferation via AMP-Activated Protein Kinase Activation.
701	AMP-activated protein kinase activation suppresses macrophage proliferation via p53- and p21-dependent mechanisms.
702	The results of the present study indicate that AMPK activation has an inhibitory effect on GM-CSF-induced proliferation of macrophages.
703	AMP-activated protein kinase (AMPK) activation inhibits GM-CSF-induced macrophage proliferation.
704	Suppression of macrophage proliferation by AMP-activated protein kinase.
705	AMPK activation induces p53-dependent cell cycle arrest in macrophages.
706	AMP-activated protein kinase activation suppresses Ox-LDL-induced macrophage proliferation by a p53-dependent and -independent mechanism.
707	AMP-activated protein kinase activation suppresses macrophage proliferation via induction of p53, p21 and p27.
708	AMPK activation suppresses GM-CSF-induced macrophage proliferation via p53-dependent and AMPK-dependent pathways.
709	Activation of AMP-activated protein kinase ( AMPK ) inhibits macrophage proliferation via cell cycle arrest and p53-dependent apoptosis.
710	Human Ribosomal RNA Processing Is Unique and Revealed by a Deep Functional Analysis of Human Nucleolar Proteins.
711	A human ribosomal RNA exosome with distinct exonuclease activity.
712	A comprehensive yeast proteome for nucleolar pre-rRNA processing uncovers distinct requirements in human cells.
713	The nucleolar role of the exosome is conserved across different species.
714	RNA Processing Defects in Humans Define the Role of Exosomes and Show the Need for New RNA Processing Agents.
715	Human Precursor-Ribosomal RNA Processing Is Divergent from Yeast and Associated with Ribosomopathies
716	Human ribosomal RNA processing requires proteins with no yeast homolog.
717	Identification and functional characterization of a large number of pre-rRNA processing proteins in human cells
718	Identification of unique RNA processing pathways in human and yeast.
719	The ribosomal RNA processing network is conserved in humans but differs substantially from the model organism Saccharomyces cerevisiae.
720	Reactive oxygen species act as chemical messengers involved in the control of cell migration and adhesion.
721	Reactive oxygen species (ROS) and the proteins that regulate them play important roles in the migration and adhesion of cells.
722	ROS, particularly hydrogen peroxide, and the proteins that regulate them play important roles in the migration and adhesion of cells.
723	Cell migration and adhesion are intimately linked to the reactive oxygen species that regulate these processes.
724	ROS regulate cell migration and adhesion.
725	Reactive oxygen species and proteins that regulate them play important roles in the migration and adhesion of cells.
726	Reactive oxygen species play important roles in the migration and adhesion of cells
727	Cell migration and adhesion depend on reactive oxygen species and their associated proteins.
728	Reactive oxygen species and the proteins that regulate them play important roles in the migration and adhesion of cells.
729	Reactive oxygen species (ROS ) are used to regulate cell migration and adhesion.
730	The precise mechanisms by which lithium produces its mood-stabilizing effects are not well understood.
731	Lithium has been used for over half a century for the treatment of bipolar disorder as the archetypal mood stabilizer, and has a wealth of empirical evidence supporting its efficacy in this role. Despite this, the specific mechanisms by which lithium exerts its mood-stabilizing effects are not well understood.
732	The neurobiology of lithium
733	The molecular mechanisms by which lithium regulates neurotransmission.
734	This review examines how lithium affects mood, cognition, brain structure, and neurotransmission and intracellular and molecular pathways.
735	The action of lithium on the neuroendocrine system.
736	Lithium is the most commonly used mood stabilizer, however it has been shown to work by a wide range of mechanisms.
737	Mechanisms of Lithium's Effects on the Brain and Body
738	Lithium affects mood and cognition through a complex neurotransmitter system.
739	Bipolar disorder treatment involves lithium and is associated with a variety of neurochemical changes that may contribute to its mood-stabilizing effects.
740	Autoantibodies against cytoplasmic protein may trigger and contribute to disease development and pathogenesis.
741	To understand the pathogenic mechanisms of ANCA, we first concentrate on the mechanisms triggering the development of ANCA.
742	This article summarizes the current understanding about the pathogenesis of diseases associated with ANCAs.
743	Mechanisms of neutrophil activation by antineutrophil cytoplasm antibodies ( ANCA )
744	Understanding the pathogenesis of ANCA: from trigger to disease mechanism.
745	The role of antineutrophil cytoplasm autoantibodies in disease mechanisms and pathogenesis.
746	To describe mechanisms triggering the development of ANCA, contributions of ANCA to clinical symptoms, and the pathogenic role of ANCA.
747	Mechanisms involved in antineutrophil cytoplasm autoantibody pathogenesis
748	Mechanisms of the pathogenic role of antineutrophil cytoplasm autoantibodies.
749	This review focuses on the etiologies of diseases associated with antineutrophil cytoplasm autoantibodies (ANCA), including the potential role of microbial superantigens and the possible defect(s) in the progression of apoptosis or in the removal of apoptotic cells.
750	The PS2 integrins regulate the execution of left-right asymmetry in the development of the male genitalia of drosophila.
751	Insect morphogenesis is regulated by hormone-responsive integrins and ligands.
752	Tenectin is a new extracellular matrix ligand required for proper morphogenesis of the adult wing and male genitalia.
753	We describe the gene structure of a newly described ECM molecule, tenectin, and demonstrate that it is a hormonally regulated ECM protein required for proper morphogenesis of the adult wing and male genitalia.
754	Tenectin is a novel extracellular matrix protein required for looping morphogenesis in the male genitalia of the fruit fly Drosophila melanogaster.
755	Tenectin: a newly discovered ligand for the PS2 integrins, and evidence for a novel integrin-ligand complex in fly wing morphogenesis.
756	The genetics and characterization of a new protein that is required for morphogenesis of the adult fly wing and male genitalia.
757	Identification of tenectin, a new ligand of the PS2 integrins.
758	Tenectin Is a Hormonally Regulated Extracellular Matrix Protein Required for Proper Morphogenesis in the Drosophila Male Genitals
759	Tenectin Is a Hormonally Regulated ECM Protein Required for Proper Morphogenesis of the Adult Flies Wing and Male Genitalia.
760	Fetal growth parameters were well-represented among the smoothed centiles.
761	Our study provides the first evidence that a cohort-based approach is feasible for the purpose of developing fetal growth standards.
762	The Fetal Growth Longitudinal Study produced international growth standards for fetuses with no significant difference between the observed and smoothed curves.
763	Fetal growth measurement is an established clinical tool.
764	The findings suggest that international growth standards for fetuses can be developed and used in the same way as growth standards for children.
765	The longitudinal method employed here to develop international growth standards for fetuses has yielded a set of reference measurements that are consistent with each other.
766	WHO International Growth Standards for Fetal Morphology in a Cross-Cultural Population.
767	We established international fetal growth standards using the same methods and approach used to produce WHO growth standards for infants and children.
768	The results of this longitudinal cohort study indicate that international standards for fetal growth could be produced using existing methods.
769	These findings suggest that a small number of women have an intrauterine growth restriction and that fetal growth standards should be adjusted for individual growth differences among women.
770	" The duration of the QT interval is an important predictor of all-cause mortality in patients with NIDDM. "
771	Prolonged QT interval is an independent predictor of cardiovascular mortality in patients with NIDDM.
772	Prolonged corrected QT interval is an independent predictor of mortality in non-insulin-dependent diabetes.
773	Prolonged QTc and QT dispersion are independent predictors of mortality.
774	QT interval length is an independent predictor of mortality in non-insulin-dependent diabetes.
775	QTc-max interval is an independent predictor of all-cause mortality and cardiovascular mortality in patients with non-insulin-dependent diabetes mellitus
776	QTc-max is a predictor of cardiovascular mortality in patients with non-insulin-dependent diabetes mellitus.
777	Increased QT interval length is associated with mortality in non-insulin dependent diabetes mellitus.
778	Longer QT interval (QTc-max) but not dispersion predicted mortality in non-insulin-dependent diabetes mellitus.
779	Prolonged QT interval length and QT dispersion are independent predictors of all-cause mortality in NIDDM patients.
780	Cdk5 Activity Regulates the Subcellular Localization of P35-Cdk5 and P39-Cdk5
781	Phosphorylation of Cdk5-activator complexes affects their subcellular localization.
782	Cdk5 regulates the subcellular localization of neuronal activators p35 and p39.
783	This article suggests that the subcellular localization of p35-Cdk5 and p39-Cdk5 is determined by its kinase activity, and also implicate a role for p39-Cdk5 in the nucleus
784	Phosphorylation of p35- and p39-Cdk5 activator complexes by Cdk5 determines subcellular localization.
785	Cdk5 activity regulates the subcellular localization of its neuronal activators, p35 and p39
786	Cdk5 activity regulates the localization of Cdk5-activator complexes
787	Cdk5 Activity Determines the Subcellular Localization of p35-Cdk5 and p39-Cdk5.
788	Cdk5 Activity Determines Subcellular Localization of P35-Cdk5 and p39-Cdk5 in Neurons
789	Cdk5 activity determines the subcellular localization of the cyclin-dependent kinase 5 -activator complexes.
790	A higher concentration of methane detected by breath testing is a predictor of significantly greater obesity in overweight subjects.
791	An association between methane detected in breath and obesity in human subjects.
792	Higher methane concentrations in human subjects are associated with elevated BMI.
793	High breath methane concentrations associated with increased BMI.
794	A higher concentration of methane is a predictor of significantly greater obesity in overweight subjects.
795	This is the first human study to demonstrate that a higher concentration of methane detected by breath testing is a predictor of significantly greater obesity in overweight subjects.
796	A higher concentration of methane detected by breath testing is a predictor of significantly greater obesity in overweight subjects.
797	The association between methane and obesity in humans.
798	The results of the present study indicate that higher breath methane concentrations are associated with greater obesity in overweight subjects.
799	Higher breath methane concentrations are associated with greater obesity in overweight subjects.
800	Trpm4 expression is required for secondary vascular hemorrhage in the central nervous system.
801	Transient receptor potential M4 ( Trpm4 ) is a major contributor to secondary injury associated with capillary fragmentation following spinal cord injury.
802	TRAP M4-Dependent Capillary Fragmentation Mediates Secondary Brain Injury
803	Trpm4 Is a Potentiator of Capillary Fragmentation after Spinal Cord Injury
804	Trpm4 is a Trp protein involved in blood vessel fragmentation and neuronal damage following spinal cord injury.
805	De novo expression of TrpM4 is required for manifestation of central nervous system injury.
806	Trpm4 expression in the vascular endothelium contributes to the initiation and development of ischemic tissue destruction in the spinal cord
807	Trpm4 promotes the proliferation of activated neurons following central nervous system injury.
808	Trpm4 expression is necessary for expansion of secondary hemorrhage in the central nervous system.
809	This is the first example of a Trp channel that must undergo de novo expression for manifestation of central nervous system pathology.
810	Neurovascular coupling involves a multidimensional process.
811	The neurovascular unit plays a vital role in maintaining brain health.
812	The neurovascular unit: a comprehensive review of a multidimensional system for coupling neural activity and blood flow in the brain.
813	The brain is not merely an organ, but an intricately interconnected system of neurons, blood vessels, and supporting cells.
814	The neurovascular unit plays an integral role in neuronal-vascular coupling.
815	Neurovascular coupling is a multidimensional process involving numerous types of cells in the brain.
816	Neurovascular coupling is more than local: The neurovascular unit coupling neural activity and blood flow is more than local.
817	The neurovascular unit is an integral, integral component of brain function.
818	The neurovascular unit is the brain-blood interface.
819	Neurovascular coupling: a multidimensional process involving diverse cells.
820	Population-based prevalence of cerebral palsy in extremely prematurity has been steadily decreasing.
821	Cerebral palsy prevalence rates for extremely premature infants: changes in a 30-year prospective cohort study.
822	Population-based prevalence of cerebral palsy among extremely premature infants in Northern Alberta has decreased steadily over the past decade.
823	Cerebral palsy prevalence rates among extremely premature infants have been reduced in recent years.
824	Cerebral palsy rates have decreased among children with extremely low birth weight over 30 years.
825	Population-based cerebral palsy prevalence rates decrease with increasing gestational age and weight among extremely premature infants.
826	Population-based, Gestational Age-Specific Prevalence Rates of Cerebral Palsy among Extremely Premature Infants Over Time.
827	The population-based prevalence rate of cerebral palsy among extremely premature infants in Northern Alberta is now decreasing over time
828	Increased survival of extremely prematurity has reversed population-based changes in cerebral palsy prevalence over 30 years.
829	Population-based Cerebral Palsy Prevalence Rates Are Reduced in Extremely Premature Infants: A Prospective Longitudinal Outcome Study.
830	MicroRNA-22 regulates TET2 in hematopoietic malignancy
831	Aberrations in the miR-22/TET2 regulatory network are common in hematopoietic malignancy
832	Upregulated microRNA-22 causes deregulated hematopoietic differentiation and hematopoietic tumorigenesis.
833	MiR-22 deregulation promotes leukemia through TET2 inhibition.
834	Transgenic mice expressing the microRNA miR-22 display increased hematopoietic stem cell self-renewal and development of myelodysplastic syndrome.
835	The miR-22/TET2 network regulates hematopoietic stem cell self-renewal and differentiation.
836	This study identifies the microRNA 22 as a potent proto-oncogene that drives hematopoietic cancer.
837	Using mouse models and human disease specimens, we identify miR-22 as a proto-oncogene with an important role in hematopoietic malignancy.
838	miR-22 is a proto-oncogene associated with hematopoietic malignancy.
839	Identification of miR-22 as a potent proto-oncogene implicated in hematopoietic malignancy and aberrations in the miR-22/TET2 regulatory network.
840	Increased ratio of arachidonic to docosahexaenoic acid in cystic fibrosis-associated mucosal and rectal tissue.
841	Humans with mutations in the CFTR gene have increased arachidonic acid and decreased docosahexaenoic acid levels in CFTR-expressing tissue.
842	Increased levels of arachidonic acid and decreased levels of docosahexaenoic acid are present in CFTR-expressing tissue in patients with cystic fibrosis.
843	Increased ratios of arachidonic to docosahexaenoic acid in tissues expressing the cystic fibrosis transmembrane conductance regulator gene.
844	Patients with cystic fibrosis have alterations in fatty acids in CFTR-expressing tissues.
845	Increased levels of arachidonic acid are present in the CFTR-expressing tissue of patients with cystic fibrosis.
846	Increased ratio of arachidonic acid to docosahexaenoic acid in mucosal and submucosal nasal- and rectal-biopsy specimens from subjects with cystic fibrosis.
847	Increased ratio of arachidonic acid to docosahexaenoic acid is present in human CFTR-expressing tissue.
848	Increased arachidonic acid levels and decreased docosahexaenoic acid levels in tissues expressing CFTR.
849	Cystic fibrosis-related mutations increase arachidonic acid and decrease docosahexaenoic acid in CFTR-expressing tissues.
850	Rapid eye movement (REM) sleep has been associated with respiratory and cardiac disturbances in infancy.
851	The predominance of REM sleep during the first months of life makes this a risk factor for abnormal sleep-related events.
852	The effects of sleep on the cardiorespiratory control system in infancy.
853	The effects of sleep on the cardiorespiratory control system during the first months of life.
854	Rapid-eye movement (REM) sleep may be a risk factor for abnormal sleep-related events during early infancy.
855	Sleep and respiratory control during early infancy.
856	The predominance of REM sleep may be a risk factor for abnormal sleep-related events during early infancy.
857	Developmental changes in the sleep pattern influence various mechanisms involved in cardiorespiratory control.
858	The effects of rapid-eye movement (REM) sleep on various mechanisms involved in cardiorespiratory control are of particular significance during the postnatal period since newborns spend much of their time in this sleep state.
859	The effects of rapid-eye movement sleep on respiratory and cardiac control during infancy.
860	5-Hydroxymethylcytosine is reduced in advanced melanomas.
861	High 5hmC and low TET2 expression in human nevi versus melanoma.
862	5hmC and TET2 levels are significantly reduced in advanced melanomas compared with nevi and thin melanomas.
863	Reduced 5-hydroxymethylcytosine levels and ten-eleven translocation 2 protein expression in nevi and advanced melanomas.
864	5hmC and TET2 expression are significantly reduced in advanced melanomas compared with nevi and thin melanomas.
865	TET2 expression is associated with reduced 5-hydroxymethylcytosine (5hmC) levels in melanoma.
866	Increased levels of 5-hydroxymethylcytosine and TET2 expression in nevi and thin melanomas.
867	Reduced 5-hydroxymethylcytosine and TET2 expression in melanoma suggest a potential epigenetic role.
868	5-Hydroxymethylcytosine and ten-eleven translocation 2 protein expression are significantly reduced in melanoma compared with nevi and thin melanomas.
869	5hmC and TET2 Expression are Markedly Decreased in Advanced Melanoma.
870	Although the field is growing, its medical literature lags behind, with nearly all of the scholarly publications lacking significant data collection.
871	Short-term medical service trips lack an empirical base for recommendations.
872	The field of short-term medical service trips has an urgent need for empirical data.
873	A systematic review demonstrating a lack of empirical data for short-term medical service trips.
874	A systematic review of short-term medical service trip literature is needed to inform policy and practice.
875	A systematic review of publications shows a significant gap in empirical research of short-term medical service trips.
876	There is an urgent need to develop an empirically grounded literature on medical service trips.
877	Evidence-based scholarly publications for short-term medical service trips : a systematic review
878	The literature is largely absent of data on the impact of medical service trips.
879	Few studies on the short-term medical service trip (ST-MST) are available, and even those that have been published generally report on surgical trips.
880	The maintenance of adequate bone mass is dependent upon the controlled and timely removal of old, damaged bone. This complex process is performed by the highly specialized, multinucleated osteoclast. Over the past 15 years, a detailed picture has emerged describing the origins, differentiation pathways and activation stages that contribute to normal osteoclast function.
881	Recent advances in understanding the role of the osteoclast in maintaining bone homeostasis.
882	In recent years, a detailed picture has emerged describing the origins, differentiation pathways, and activation stages that contribute to normal osteoclast function.
883	The osteoclast is an essential cell involved in resorptive bone turnover.
884	Osteoclastogenesis is a highly specialized and highly organized process that performs the essential function of maintaining bone mass and integrity.
885	The maintenance of adequate bone mass is dependent upon the controlled and timely removal of old, damaged bone. This complex process is performed by the highly specialized, multinucleated osteoclast. Over the past 15 years, a detailed picture has emerged describing the origins, differentiation pathways and activation stages that contribute to normal osteoclast function. This information has primarily been obtained by the development and skeletal analysis of genetically modified mouse models. Mice harboring mutations in specific genetic loci exhibit bone defects as a direct result of aberrations in normal osteoclastogenesis, ion
886	Osteoclast biology: a review of genetic mouse models
887	Osteoclasts, a key component of bone homeostasis
888	Genetic mouse models of osteoclastogenesis have led to detailed observations of osteoclast origins, differentiation pathways and activation stages that contribute to normal function.
889	The past 15 years have provided a detailed picture describing the origins, differentiation pathways and activation stages that contribute to normal osteoclast function.
890	LYSINE-79 METHYLATION OF HISTONE H3 REGULATES REPAIR OF UV DAMAGE.
891	Lysine-79 Methylation of Histone H3 Plays Roles in Multiple Pathways of UV Repair.
892	Histone lysine-79 methylation plays distinct roles in the repair of UV damaged DNA.
893	The response to UV damage requires histone H3 lysine-79 methylation.
894	A Dot1p-dependent methylation of histone H3 lysine-79 is critical for efficient repair of UV damage in the yeast Saccharomyces cerevisiae.
895	Lysine-79 Methylation plays Distinct roles in the Response to UV Damage
896	Histone H3 methylation at lysine-79 plays distinct roles in UV-damage repair
897	Lysine-79 methylation of histone H3 by Dot1p coordinates distinct repair pathways during UV damage response.
898	Lysine-79 Methylation of Histone H3 in Saccharomyces cerevisiae plays distinct roles in UV Repair
899	Lysine-79 methylation regulates UV response in S. cerevisiae.
900	Drowning in children has remained the most common cause of accidental death.
901	Deaths by drowning in children in the United Kingdom fell from 149 to 74 between 1998 and 2002.
902	Over the past decade, a significant proportion of the drownings have occurred in the pool or the sea, and this remains a major health problem for young children, their parents and carers.
903	Detailed information on drowning in children is not routinely collected by offices of national statistics.
904	Since 1998 there have been significant reductions in drowning in children in the United Kingdom
905	Over the last 10 years there has been an upward trend in deaths by drowning in children.
906	Changing child drowning patterns in the United Kingdom.
907	In 1998-9, the British children's leisure water drowning death rate fell by 33% from 149 in 1988-9 to 91.
908	Children are not safe in water and drowning rates have fallen over the last 10 years
909	drowning is the leading cause of unnatural death in children under 4 in the United Kingdom
910	Salmonella/Campylobacter infection is associated with an increased risk of inflammatory bowel diseases.
911	Salmonella and Campylobacter gastroenteritis are associated with an increased risk of inflammatory bowel disease: a population-based cohort study.
912	Risk of Inflammatory Bowel Disease Increases After an Episode of Salmonella/Campylobacter Infection.
913	Salmonella and Campylobacter infections increase the risk of developing inflammatory bowel disease
914	Increased risk of inflammatory bowel diseases in individuals with documented salmonella or campylobacter gastroenteritis.
915	Salmonella or campylobacter infection increased risk of inflammatory bowel diseases
916	Salmonella/Campylobacter gastroenteritis is associated with an increased risk of inflammatory bowel disease.
917	Salmonella and campylobacter gastroenteritis increase the risk of inflammatory bowel disease.
918	Infection with Salmonella or Campylobacter is associated with an increased risk of inflammatory bowel disease.
919	Salmonella/Campylobacter infection is associated with an increased risk of inflammatory bowel disease.
920	The hepatitis C virus nonstructural protein 3-4A protease as an important therapeutic target.
921	Hepatitis C virus NS3-4A is an essential target for antiviral intervention
922	NS3-4A is an essential component of the viral replication complex and prime target for antiviral intervention.
923	NS3-4A is a multifunctional protein important for the survival and proliferation of the hepatitis C virus.
924	A review of hepatitis C virus NS3-4A protein complex: from biochemical and structural analysis to drug design
925	Hepatitis C virus nonstructural protein 3-4A protease is an essential component of the viral replication complex and a prime target for antiviral intervention.
926	NS3-4A is an essential component of the viral replication complex and prime target for antiviral intervention
927	The NS3-4A protease and hepatitis C virus: A protease/RNA helicase complex that is essential for viral replication and plays a key role in the pathogenesis of the virus.
928	NS3-4A nonstructural protein 3-4A is a critical player in the pathogenesis of chronic hepatitis C virus infection.
929	A key role for the hepatitis C virus nonstructural protein 3-4A complex in the pathogenesis of chronic hepatitis C
930	Increased IL-17 mRNA expression in circulating mononuclear cells in patients with multiple sclerosis.
931	Increased numbers of IL-17 mRNA expressing mononuclear cells in patients with MS and acute aseptic meningoencephalitis.
932	Increased numbers of IL-17 mRNA expressing mononuclear cells in blood and CSF in multiple sclerosis.
933	Increased numbers of IL-17 mRNA expressing mononuclear cells in blood and CSF are associated with clinical exacerbation in patients with multiple sclerosis.
934	Increased IL-17 expression in mononuclear cells during clinical exacerbation of multiple sclerosis.
935	In this report, we demonstrated increased numbers of IL-17 mRNA expressing monocytes in CSF and blood during clinical exacerbation in patients with MS and acute aseptic meningoencephalitis.
936	Increased numbers of IL-17 mRNA expressing blood MNC in patients with MS.
937	In situ hybridisation detection of interleukin-17 mRNA expressing mononuclear cells in multiple sclerosis.
938	Interleukin 17 expression in cerebrospinal fluid of patients with multiple sclerosis
939	Increased numbers of IL-17 mRNA expressing mononuclear cells are associated with multiple sclerosis disease activity and exacerbation.
940	The history of dementia research in Europe
941	A general overview of the history of dementia research in Europe and how it compares with that in the United States.
942	A history of dementia research in Europe.
943	The review highlights the common issues which both U.S. and European researchers have identified and attempted to tackle.
944	A review of the history of dementia research in Europe and the United States.
945	This review focuses on how major dementia research has evolved in the United States and Europe and what common issues have been identified.
946	The history of dementia research in Europe and the United States.
947	Alzheimer's disease - research developments in Europe and the United States.
948	A review of dementia research in Europe
949	Major research effort in both the United States and Europe has been targeted toward understanding the pathogenesis and epidemiology of dementia.
950	CPHPC and an Anti-SAP Monoclonal Antibody Improve Liver Function and Reduce Amyloid Deposition in Patients With Systemic Amyloidosis.
951	A novel approach to the treatment of systemic amyloidosis combining IgG antibodies with a protease inhibitor.
952	Treatment of serum amyloid P component deficient patients with monoclonal antibodies induced clinically detectable amyloid clearance from the liver and some other tissues.
953	Treatment with CPHPC followed by an anti-SAP antibody triggers clearance of amyloid deposits from liver and other tissues.
954	The findings suggest that an anti-SAP antibody can safely and effectively clear amyloid from the liver and other organs.
955	Treatment with CPHPC and an anti-SAP antibody triggered safe clearance of amyloid fibril deposits in the liver and other tissues.
956	Targeting amyloid deposits with an anti-SAP antibody.
957	An antibody to a specific protein of amyloid fibrils is associated with a decrease in the load of amyloid deposits and with a reduction in the symptoms of systemic amyloidosis.
958	Serum amyloid P component depletion and anti-SAP antibody therapy can improve liver function in patients with systemic amyloidosis.
959	A Phase I Trial of an Anti-Serum Amyloid P Component Antibody for Systemic Amyloidosis
960	This book is an exhaustive and engrossing delineation of Wolff's long study and understanding of headache.
961	In this book, there is an engrossing delineation of Wolff's long study and understanding of headache.
962	Has brought certain aspects of headache up to date, most of them having to do with drug therapy.
963	There has never been a book on headache that came close to that of the late Harold Wolff.
964	There has never been a book on headache that came close to that of the late Harold Wolff.
965	The emphasis on total therapy rather than simply drug therapy has been preserved.
966	There has never been a book on headache that came close to that of the late Harold Wolff.
967	A thorough review of the field with the benefit of the experiences of the author and other contributors.
968	The new edition, revised by Dalessio, serves to bring certain aspects of headache up to date, most of them having to do with drug therapy.
969	The new edition, revised by Dalessio, serves to bring certain aspects of headache up to date, most of them having to do with drug therapy.
970	Behcet's disease with an underlying leukaemia.
971	A lymphoproliferative disorder in a patient with Behcet's disease.
972	Behcet's disease masquerading as a lymphoproliferative disorder.
973	Behcet's disease in a woman.
974	Behcet's disease and immune complex mediated vasculitis.
975	A case of Behcet's disease and a mixed cryoglobulinemia in a woman with lymphoproliferative disorder.
976	A woman with a poorly differentiated lymphoproliferative disorder developed cryoglobulinemia and an immune complex mediated vasculitis with improvement on prednisone and chlorambucil therapy.
977	The following cases are reported for the first time:
978	The patient presented a rare case of the late complication of Behcet's disease.
979	Long term follow up of Behcet's disease in a patient.
980	An easy to use command-line tool for the trimming of small RNA sequencing reads.
981	We developed the command-line tool cutadapt to trim short reads from long reads with the purpose of removing the 3' adapter.
982	A Command-line Tool for Trimming 3' Adapters from RNA Sequences
983	cutadapt is a command-line tool to trim 3' adapter sequences from short RNA-seq reads.
984	In this paper we describe cutadapt, a new and powerful tool to remove adapters from small RNA sequences.
985	The adapter trimming pipeline cutadapt is presented.
986	Cutadapt allows efficient trimming of adapters from small RNA sequencing data from any platform
987	We developed the command-line tool cutadapt, which supports 454, Illumina and SOLiD (color space) data, offers two adapter trimming algorithms, and has other useful features.
988	An easy to use command-line tool for adapter trimming of small RNA sequencing data
989	Cutadapt is an easy-to-use command-line tool to remove the 3' adapter from short RNA sequence data.
990	Temperature trends over Canada are increasing and increasingly pronounced for southern Canada since 1900.
991	Temperatures have increased in Canada since 1950.
992	Using the second generation of the homogenized Canadian Climate Trend Data Set, we present the average annual temperature for the period 1950–2010, and for Southern Canada for the period 1900–2010.
993	Temperature has been rising across Canada for the past 61 years.
994	For 1950–2010, the annual mean temperature averaged over the country shows a positive trend of 1.5°C for the past 61 years.
995	Temperature has increased in Canada for the last 61 years
996	This study presents a second generation of homogenized monthly mean surface air temperature data set for Canadian climate trend analysis.
997	The warming trends of the surface air temperature of Canada were estimated based on the second generation of homogenized monthly mean surface air temperature data set for Canadian climate trend analysis.
998	An increase in mean temperature was observed in both areas in recent years.
999	The annual mean temperature averaged over the country shows a positive trend of 1.5°C for the past 61 years.
